Schistosomiasis Treatment Market 2019 Global Industry Insights, Outlook, and Opportunity Analysis | Chemos GmbH & Co. KG, Shin Poong Pharma, Meher Distributors, Merck
Request For Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/889
Development of novel vaccines for the treatment of schistosomiasis is expected to propel the growth of schistosomiasis treatment market
According to the University of Nottingham in 2017, researchers have discovered the infiltrin protein on a parasitic egg, which may be responsible for this infectious disease. This discovery is expected create opportunities for targeted development of vaccination and treatments. Moreover, the College of Science at Oregon State University (OSU), discovered the new protein in Biomphalaria glabrata snail, known as Grctm6 in 2017. Research is in progresses use this protein as a biocontrol agent against schistosomiasis.
Dr. Afzal Siddiqui, a professor at the Tech Health Sciences Center, in 2015, received a patent for vaccine to treat schistosomiasis. The vaccine demonstrated successful results in pre-clinical trials and is undergoing clinical trials for safety and efficacy evaluation. Patent applications have also been filed in China, India, and Brazil. Dr. Siddiqui intends to develop and distribute this vaccine at affordable rates for the infected people. This is expected to stimulate growth in the schistosomiasis treatment market in future.
Increasing demand for preventive chemotherapy against schistosomiasis is expected to favor the growth of schistosomiasis treatment market
According to the World Health Organization (WHO) in 2017, around 92% people require preventive chemotherapy for schistosomiasis in Africa. Around 75% of school aged children are at risk of morbidity from schistosomiasis and soil-transmitted helminthiasis. Further, 78% of the economies have an epidemic outbreak of schistosomiasis and 52% of those countries require preventive chemotherapy.
The major players in schistosomiasis treatment market include, Chemos GmbH & Co. KG, Shin Poong Pharma.Co. Ltd., Meher Distributors Pvt. Ltd., Merck & Co., Salvensis, Bayer AG, LondonPharma Ltd, Merck & Co., Inc., 3S Corporation Kancera AB, aj Pharmaceuticals Ltd., Avanscure Lifesciences Pvt. Ltd, CBC Pharma., VHB Life Science Inc., Samarth Pharma Pvt. Ltd., Taj Pharmaceuticals Ltd., and Egyptian International Pharmaceuticals Industries Co SAE (EIPICO). These companies offer various drugs, which are being used for preventive chemotherapy.
Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/889
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Schistosomiasis Treatment Market 2019 Global Industry Insights, Outlook, and Opportunity Analysis | Chemos GmbH & Co. KG, Shin Poong Pharma, Meher Distributors, Merck here
News-ID: 1721494 • Views: 460
More Releases from Coherent Market Insights
Respiratory Disease Testing Market Forecast, Research Findings and Recent Studie …
The global Respiratory Disease Testing Market research report thoroughly explains each and every aspect related to the Respiratory Disease Testing Market, which facilitates the report's reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. The growth trend forecasted on account of a thorough examination offers in-depth information regarding the global Respiratory Disease Testing Market. A pathway of development is offered by
Cancer Diagnostics Market Impact Analysis of Covid-19 - Abbott Laboratories, F. …
The Cancer Diagnostics Market is expected to have a highly positive outlook over the forecast period 2020-2026 according to a Cancer Diagnostics Market research report. The Cancer Diagnostics report stresses the most recent advancements, development, new chances, and lethargic traps. It gives a comprehensive position of the Cancer Diagnostics. The Cancer Diagnostics research report covers the present scenario and the growth prospects of the Global Cancer Diagnostics Industry for 2020-2026.
Asthma & COPD Market Impact Analysis of Covid-19 - AstraZeneca, Novartis AG, Gla …
The Asthma & COPD Market is expected to have a highly positive outlook over the forecast period 2020-2026 according to a Asthma & COPD Market research report. The Asthma & COPD report stresses the most recent advancements, development, new chances, and lethargic traps. It gives a comprehensive position of the Asthma & COPD. The Asthma & COPD research report covers the present scenario and the growth prospects of the Global
COVID-19 Detection Kits Market Impact Analysis of Covid-19 - F. Hoffmann-La Roch …
The COVID-19 Detection Kits Market is expected to have a highly positive outlook over the forecast period 2020-2026 according to a COVID-19 Detection Kits Market research report. The COVID-19 Detection Kits report stresses the most recent advancements, development, new chances, and lethargic traps. It gives a comprehensive position of the COVID-19 Detection Kits. The COVID-19 Detection Kits research report covers the present scenario and the growth prospects of the Global
More Releases for Pharma
Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Clomifene Citrate Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Clomifene Citrate Market" across the global, regional and country level. The report provides 360° analysis of "Clomifene Citrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Clomifene Citrate industry, and estimates the future trend of Clomifene Citrate market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business